ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1963

Variation in Quality of Care Among Patient Sociodemographic Groups in RISE Practices

Zara Izadi1, Gabriela Schmajuk2 and Jinoos Yazdany3, 1University of California San Francisco, San Francisco, CA, 2University of California, San Francisco, Atherton, CA, 3University of California, San Francisco, San Francisco, CA

Meeting: ACR Convergence 2020

Keywords: Disparities, quality of care, race/ethnicity, rheumatoid arthritis, socioeconomic factors

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2020

Title: Measures & Measurement of Healthcare Quality (1963–1967)

Session Type: Abstract Session

Session Time: 12:00PM-12:50PM

Background/Purpose: Previous studies have shown that sociodemographic factors are associated with quality of care.  Using the Rheumatology Informatics System for Effectiveness (RISE) registry, we assessed whether the area deprivation index (ADI) and/or race/ethnicity was associated with provider performance on quality measures among patients with rheumatoid arthritis (RA). 

Methods: We analyzed data collected on all patients with a diagnosis of RA who had at least one clinic visit between January 2015 and December 2017.  We examined performance on disease activity assessment, functional status assessment, tuberculosis (TB) screening prior biologic start and blood pressure (BP) control. Using mixed-effects regression, we assessed the effect of area deprivation (as measured by the ADI, above or below the median percentile, where higher scores reflect more deprivation) and race/ethnicity on measure performance and on change in performance over time. Since practice characteristics could mediate this effect, we controlled for practice type, number of providers, region, and eHR software. Analyses accounted for clustering by practice and by patient.

Results: Data from 58,432 patients from 54 practices was examined. Mean age was 63±14 years, 77% were female, and 69% were Caucasian. Over time, there were significant improvements in performance on functional status assessment (+13.5% per year) and disease activity assessment (+8.8%), smaller improvements in performance on TB screening (+2.9%) and no improvements in performance on BP control. Performance on disease activity assessment and functional status assessment was comparable across all subgroups (Table). Both measures improved faster over time among patients with higher ADI, but improvements were slower among African Americans and Hispanics than Caucasians.  Performance on TB screening was higher among African Americans (59.0%) and Hispanics (58.0%) than Caucasians (54.7%) and improved faster over time among Hispanics (+7.7% points per year) than Caucasians (3.9%, p< 0.05) and among patients with higher ADI (+4.7%) than those with lower ADI (+2.7%, p< 0.001). Performance on BP control was lower among African Americans (59.6%) and patients with higher ADI (62.7%) than Caucasians (64.5%, p< 0.001) and patients with lower ADI (65.3%, p< 0.001), respectively. 

Conclusion: Although performance on quality measures is improving overall, we found important differences across sociodemographic groups. Non-Caucasians and those with lower socioeconomic status (SES) had less improvement compared to Caucasians and those with higher SES.  TB screening seems to be improving more among higher risk groups. Consistent with studies in the general medical literature, BP control was lowest among African Americans. To address health disparities, future quality improvement initiatives should target patient groups with persistent gaps in quality of care.


Disclosure: Z. Izadi, None; G. Schmajuk, None; J. Yazdany, Eli Lilly, 1, Astra Zeneca, 1.

To cite this abstract in AMA style:

Izadi Z, Schmajuk G, Yazdany J. Variation in Quality of Care Among Patient Sociodemographic Groups in RISE Practices [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/variation-in-quality-of-care-among-patient-sociodemographic-groups-in-rise-practices/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/variation-in-quality-of-care-among-patient-sociodemographic-groups-in-rise-practices/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology